According to the latest IndexBox report, the global Nonvascular Interventional Radiology Devices market is projected to enter a sustained expansion phase, with demand expected to grow at a compound annual growth rate (CAGR) of approximately 5.8% from 2026 to 2035. This growth is driven by an increasing preference for minimally invasive procedures over traditional surgeries, particularly in oncology and other specialties. The market includes a range of devices such as embolization coils, stents, and biopsy needles. Key trends influencing the market include the professionalization of procurement processes in hospitals, an increasing focus on cost containment, and expanding healthcare investments in the Asia-Pacific region, which is expected to become the fastest-growing market. North America remains the largest revenue market, while Europe shows moderate growth. Emerging markets in Latin America and the Middle East & Africa present more fragmented opportunities due to reimbursement and infrastructure challenges. The report also highlights a shift towards outpatient procedures in ambulatory surgical centers (ASCs) and increasing use of value-based care models in hospitals, indicating that total procedural costs will be more critical in procurement decisions. The demand dynamics and competitive landscape suggest that successful companies will need to innovate continuously and provide demonstrable clinical and economic benefits.
Fri, 15 May 2026 22:31:04 GMT | IndexBox